Efficacy of Electronic Cigarettes Noninferior to Varenicline

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 30, 2024 -- For smokers who are motivated to quit, the quit rate is noninferior for electronic cigarettes (ECs) versus varenicline and is higher for ECs than nicotine replacement therapy (NRT) in the form of nicotine gum, according to a study published online Jan. 29 in JAMA Internal Medicine.

Hao-Xing Lin, Dr.P.H., from Peking University in Beijing, and colleagues conducted a randomized clinical trial at seven sites involving participants who were smoking at least 10 cigarettes per day and were motivated to quit. A cartridge-based EC, varenicline, and 2 or 4 mg nicotine chewing gum were provided for 12 weeks and accompanied by minimal behavioral support. Sustained abstinence from smoking at six months was the primary outcome. A total of 1,068 participants were included and randomly assigned to the EC, varenicline, and NRT arms (409, 409, and 250, respectively).

The researchers found that in the EC, varenicline, and NRT arms, the six-month biochemically validated abstinence rates were 15.7, 14.2, and 8.8 percent, respectively. The quit rate was noninferior in the EC versus the varenicline arm (absolute risk reduction, 1.47 percent; 95 percent confidence interval, −1.41 to 4.34 percent) and was higher in the EC versus the NRT arm (odds ratio, 1.92; 95 percent confidence interval, 1.15 to 3.21). During the initial three months, treatment adherence was similar in all study arms; 62.8 percent of participants in the EC arm were still using ECs at six months, while in the other arms, interventions were no longer used.

"As 63 percent of participants in the EC arm still used their products at six months, further studies are needed to assess whether such use is beneficial or harmful," the authors write.

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords